Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
In the world of millennial celebrities navigating their 30s and 40s, midlife weight gain has become a relatable challenge. According to Mayo Clinic endocrinologist Dr. Daniela Hurtado Andrade, this is very common, particularly in women, due to waning muscle mass that slows metabolism. Strength training and calorie cuts often fall short because the body sends persistent hunger signals, making long-term weight loss tough. That's where GLP-1 medications like Ozempic come in, mimicking hormones to suppress appetite and regulate blood sugar—a key factor for those with weight issues tied to diabetes, as noted by the Cleveland Clinic.
Understanding GLP-1 Medications: How Ozempic and Similar Drugs Work
GLP-1 receptor agonists, such as Ozempic (semaglutide), Wegovy (higher-dose semaglutide), and Mounjaro (tirzepatide), target glucagon-like peptide-1 receptors in the body. At a basic level, they suppress appetite by masking normal "feed me" sensations while slowing gastric emptying and improving insulin sensitivity. This dual action helps with weight management beyond traditional diets, especially during midlife when hormonal shifts and muscle loss complicate efforts.
These drugs aren't quick fixes; they require medical supervision. Common side effects include nausea, vomiting, and fatigue, but many users adapt over time. For patients considering GLP-1s, discussing family history, diabetes risk, and lifestyle with a doctor is essential. Tools like Shotlee can help track symptoms, side effects, or injection schedules for better management.
Why Midlife Weight Gain Hits Millennials Hard
Dr. Hurtado Andrade highlights how metabolism dips with age-related muscle loss (sarcopenia), exacerbating weight gain. Women often face additional hurdles from perimenopause. Unlike younger years, simply exercising more or eating less doesn't override the body's hunger defenses, leading many—including Hollywood's millennial "who's who"—to GLP-1s as popularity surges.
Celebrity Stories: Millennial Stars Open Up About Ozempic and GLP-1s
From comedians to athletes, these familiar names have shared candid before-and-after insights, calling out secretive peers and normalizing GLP-1 use.
Amy Schumer: From Vomiting to Greater Success
Comedian Amy Schumer has slimmed down significantly in recent years. Her first trial with Wegovy was rough: "I was like bedridden," she admitted on Howard Stern's show (via People), citing vomiting and energy loss. Switching to Mounjaro brought better results. Later on Ozempic, she told "Watch What Happens Live With Andy Cohen" in 2023, "I was one of those people that felt so sick and couldn't play with my son." Schumer accused some celebs of "lying" about their GLP-1 use, urging them to "'fess up already."
Golnesa 'GG' Gharachedaghi: Transparent Injection Tutorials
Reality TV star Golnesa 'GG' Gharachedaghi is keeping it real with Ozempic. In a 2023 Instagram video, she demonstrated how to inject the drug—always best done under provider guidance for optimal strategies. Fans had mixed reactions: one noted, "It's because you are 41. It's normal," while another questioned the "skeleton look." GG echoed Schumer, admonishing secretive celebs: "We know who you are." Her openness has won praise from many.
Chrissy Teigen: Post-Miscarriage Weight Struggles
Model Chrissy Teigen turned to Ozempic after a miscarriage left her "stuck" with pregnancy weight. On her "Self-Conscious with Chrissy Teigen" podcast, she described "force-feeding" herself due to suppressed appetite: "Logically you need food to have energy." Teigen, who dislikes diets, found the lack of hunger ironic and uncomfortable.
